SCOPUS 정보 검색 플랫폼

Journal of Bone and Mineral Research

Volumn 20, Issue 11, 2005, Pages 2064-2065

Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk? [2]

(4) Bone, Henry G a Santora, Arthur C b Chattopadhyay, Arghya b Liberman, Uri c

a Michigan Bone and Mineral Clinic (United States)

b MERCK RESEARCH LABORATORIES (United States)

c TEL AVIV UNIVERSITY (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BIOCHEMICAL MARKER;

AGING; BONE DENSITY; BONE FRAGILITY; BONE MINERAL; BONE REMODELING; FEMALE; FRACTURE; HUMAN; LETTER; LUMBAR SPINE; MORPHOMETRICS; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; RISK ASSESSMENT;

ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 27444447031 PISSN: 08840431 EISSN: None Source Type: Journal
DOI: 10.1359/JBMR.050912 Document Type: Letter

Times cited : (4)

References (5)

1
- 12144289279
- Ten years' experience with alendronate for osteoporosis in postmenopausal women
- Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA 2004 Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189-1199.
- (2004) N Engl J Med , vol.350 , pp. 1189-1199
- Bone, H.G.¹ Hosking, D.² Devogelaer, J.P.³ Tucci, J.R.⁴ Emkey, R.D.⁵ Tonino, R.P.⁶ Rodriguez-Portales, J.A.⁷ Downs, R.W.⁸ Gupta, J.⁹ Santora, A.C.¹⁰ Liberman, U.A.¹¹

2
- 0028851590
- Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
- The Alendronate Phase III Osteoporosis Treatment Study Group
- Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443.
- (1995) N Engl J Med , vol.333 , pp. 1437-1443
- Liberman, U.A.¹ Weiss, S.R.² Broll, J.³ Minne, H.W.⁴ Quan, H.⁵ Bell, N.H.⁶ Rodriguez-Portales, J.⁷ Downs Jr., R.W.⁸ Dequeker, J.⁹ Favus, M.¹⁰

3
- 4444255602
- Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis
- Silverman SL, Delmas PD, Kulkarni PM, Stock JL, Wong M, Plouffe L Jr 2004 Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis. J Am Geriatr Soc 52:1543-1548.
- (2004) J Am Geriatr Soc , vol.52 , pp. 1543-1548
- Silverman, S.L.¹ Delmas, P.D.² Kulkarni, P.M.³ Stock, J.L.⁴ Wong, M.⁵ Plouffe Jr., L.⁶

4
- 0036284616
- Changes in density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents
- Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD 2002 Changes in density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 874:1586-1592.
- (2002) J Clin Endocrinol Metab , vol.874 , pp. 1586-1592
- Hochberg, M.C.¹ Greenspan, S.² Wasnich, R.D.³ Miller, P.⁴ Thompson, D.E.⁵ Ross, P.D.⁶

5
- 0142122889
- Study design in osteoporosis: A European perspective
- Kanis JA, Alexandre JM, Bone HG, Abadie E, Brasseur D, Chassany O, Durrleman S, Lekkerkerker JF, Caulin F 2003 Study design in osteoporosis: A European perspective. J Bone Miner Res 18:1133-1138.
- (2003) J Bone Miner Res , vol.18 , pp. 1133-1138
- Kanis, J.A.¹ Alexandre, J.M.² Bone, H.G.³ Abadie, E.⁴ Brasseur, D.⁵ Chassany, O.⁶ Durrleman, S.⁷ Lekkerkerker, J.F.⁸ Caulin, F.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.